ASX:OBJ

Wellfully Limited (OBJ.AX) Competitors

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Wellfully Limited (OBJ.AX) (ASX:OBJ) Vs. BUX, IME, BD1, CRL, CTE, and DVL

Should you be buying OBJ stock or one of its competitors? Companies in the industry of "diagnostics & research" are considered alternatives and competitors to Wellfully Limited (OBJ.AX), including (BUX) (BUX), 12144 (IME), BARD1 Life Sciences (BD1), Charles River Laboratories International (CRL), Cryosite (CTE), and dorsaVi (DVL).

Wellfully Limited (OBJ.AX) vs. (BUX) Stock

(BUX) (CNSX:BUX) and Wellfully Limited (OBJ.AX) (ASX:OBJ) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, analyst recommendations, profitability, dividends and valuation.

Analyst Recommendations

This is a summary of current recommendations and price targets for (BUX) and Wellfully Limited (OBJ.AX), as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(BUX)	0	0	0	0	N/A
Wellfully Limited (OBJ.AX)	0	0	0	0	N/A

Earnings & Valuation

This table compares (BUX) and Wellfully Limited (OBJ.AX)'s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(BUX)	N/A	N/A	N/A	N/A	N/A
Wellfully Limited (OBJ.AX)	$1.48 million	0.00	$-5,859,480.32	A($0.04)	N/A

(BUX) has higher earnings, but lower revenue than Wellfully Limited (OBJ.AX).

Profitability

This table compares (BUX) and Wellfully Limited (OBJ.AX)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(BUX)	N/A	N/A	N/A
Wellfully Limited (OBJ.AX)	N/A	N/A	N/A

Summary

Wellfully Limited (OBJ.AX) beats (BUX) on 1 of the 1 factors compared between the two stocks.

Wellfully Limited (OBJ.AX) vs. 12144 Stock

Wellfully Limited (OBJ.AX) (ASX:OBJ) and 12144 (CNSX:IME) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, analyst recommendations, earnings and institutional ownership.

Analyst Ratings

This is a summary of recent ratings and price targets for Wellfully Limited (OBJ.AX) and 12144, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellfully Limited (OBJ.AX)	0	0	0	0	N/A
12144	0	0	0	0	N/A

Earnings and Valuation

This table compares Wellfully Limited (OBJ.AX) and 12144's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellfully Limited (OBJ.AX)	$1.48 million	0.00	C$-5,859,480.32	A($0.04)	N/A
12144	N/A	N/A	N/A	N/A	N/A

12144 has lower revenue, but higher earnings than Wellfully Limited (OBJ.AX).

Profitability

This table compares Wellfully Limited (OBJ.AX) and 12144's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Wellfully Limited (OBJ.AX)	N/A	N/A	N/A
12144	N/A	N/A	N/A

Summary

Wellfully Limited (OBJ.AX) beats 12144 on 1 of the 1 factors compared between the two stocks.

Wellfully Limited (OBJ.AX) vs. BARD1 Life Sciences Stock

Wellfully Limited (OBJ.AX) (ASX:OBJ) and BARD1 Life Sciences (ASX:BD1) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, analyst recommendations, dividends, earnings and institutional ownership.

Earnings & Valuation

This table compares Wellfully Limited (OBJ.AX) and BARD1 Life Sciences' top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellfully Limited (OBJ.AX)	$1.48 million	0.00	$-5,859,480.32	A($0.04)	N/A
BARD1 Life Sciences	$464,101.00	0.00	$-5,746,881.60	A($0.07)	N/A

BARD1 Life Sciences has lower revenue, but higher earnings than Wellfully Limited (OBJ.AX).

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Wellfully Limited (OBJ.AX) and BARD1 Life Sciences, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellfully Limited (OBJ.AX)	0	0	0	0	N/A
BARD1 Life Sciences	0	0	0	0	N/A

Profitability

This table compares Wellfully Limited (OBJ.AX) and BARD1 Life Sciences' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Wellfully Limited (OBJ.AX)	N/A	N/A	N/A
BARD1 Life Sciences	N/A	N/A	N/A

Summary

Wellfully Limited (OBJ.AX) beats BARD1 Life Sciences on 2 of the 3 factors compared between the two stocks.

Wellfully Limited (OBJ.AX) vs. Charles River Laboratories International Stock

Wellfully Limited (OBJ.AX) (ASX:OBJ) and Charles River Laboratories International (CNSX:CRL) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, analyst recommendations, dividends, earnings and institutional ownership.

Earnings & Valuation

This table compares Wellfully Limited (OBJ.AX) and Charles River Laboratories International's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellfully Limited (OBJ.AX)	$1.48 million	0.00	$-5,859,480.32	A($0.04)	N/A
Charles River Laboratories International	N/A	N/A	N/A	N/A	N/A

Charles River Laboratories International has lower revenue, but higher earnings than Wellfully Limited (OBJ.AX).

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Wellfully Limited (OBJ.AX) and Charles River Laboratories International, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellfully Limited (OBJ.AX)	0	0	0	0	N/A
Charles River Laboratories International	0	0	0	0	N/A

Profitability

This table compares Wellfully Limited (OBJ.AX) and Charles River Laboratories International's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Wellfully Limited (OBJ.AX)	N/A	N/A	N/A
Charles River Laboratories International	N/A	N/A	N/A

Summary

Wellfully Limited (OBJ.AX) beats Charles River Laboratories International on 1 of the 1 factors compared between the two stocks.

Wellfully Limited (OBJ.AX) vs. Cryosite Stock

Wellfully Limited (OBJ.AX) (ASX:OBJ) and Cryosite (ASX:CTE) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Profitability

This table compares Wellfully Limited (OBJ.AX) and Cryosite's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Wellfully Limited (OBJ.AX)	N/A	N/A	N/A
Cryosite	N/A	N/A	N/A

Valuation & Earnings

This table compares Wellfully Limited (OBJ.AX) and Cryosite's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellfully Limited (OBJ.AX)	$1.48 million	0.00	$-5,859,480.32	A($0.04)	N/A
Cryosite	$8.97 million	0.00	$1.41 million	A$0.03	N/A

Cryosite has higher revenue and earnings than Wellfully Limited (OBJ.AX).

Analyst Ratings

This is a breakdown of recent recommendations for Wellfully Limited (OBJ.AX) and Cryosite, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellfully Limited (OBJ.AX)	0	0	0	0	N/A
Cryosite	0	0	0	0	N/A

Summary

Cryosite beats Wellfully Limited (OBJ.AX) on 3 of the 3 factors compared between the two stocks.

Wellfully Limited (OBJ.AX) vs. dorsaVi Stock

dorsaVi (ASX:DVL) and Wellfully Limited (OBJ.AX) (ASX:OBJ) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a summary of current recommendations and price targets for dorsaVi and Wellfully Limited (OBJ.AX), as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
dorsaVi	0	0	0	0	N/A
Wellfully Limited (OBJ.AX)	0	0	0	0	N/A

Profitability

This table compares dorsaVi and Wellfully Limited (OBJ.AX)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
dorsaVi	N/A	N/A	N/A
Wellfully Limited (OBJ.AX)	N/A	N/A	N/A

Earnings & Valuation

This table compares dorsaVi and Wellfully Limited (OBJ.AX)'s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
dorsaVi	$2.02 million	0.00	$-12,244,714.72	A($0.04)	N/A
Wellfully Limited (OBJ.AX)	$1.48 million	0.00	$-5,859,480.32	A($0.04)	N/A

Wellfully Limited (OBJ.AX) has lower revenue, but higher earnings than dorsaVi.

Summary

dorsaVi beats Wellfully Limited (OBJ.AX) on 2 of the 3 factors compared between the two stocks.